ストックスクリーナーアプリを入手
1.13
40.72%
0.327
アフターアワーズ：
1.15
0.02
+1.77%
前日終値:
$0.803
開ける：
$0.833
24時間の取引高:
7.35M
Relative Volume:
7.23
時価総額：
$5.68M
収益：
-
当期純損益:
$-28.70M
株価収益率:
-0.0228
EPS:
-49.5275
ネットキャッシュフロー:
$-3.22M
1週間 パフォーマンス:
+61.61%
1か月 パフォーマンス:
-20.98%
6か月 パフォーマンス:
-92.53%
1年 パフォーマンス:
-95.59%
1日の値動き範囲:
$0.833
$1.29
1週間の範囲:
$0.5483
$1.29
52週間の値動き範囲:
$0.5483
$35.01
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
名前
Aspire Biopharma Holdings Inc
セクター
電話
561-704-8527
住所
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
1.13 | 4.03M | 0 | -28.70M | -3.22M | -49.53 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Aspire Biopharma Holdings Inc (ASBP) 最新ニュース
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ASBP Soars: Biotech Turbulence Fuels an Unexpected 17% Jump - Bitget
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Livingston Daily
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Black Hills Pioneer
ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget
Aspire subsidiary names John Choe as western sales director By Investing.com - Investing.com South Africa
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Record Searchlight
Aspire subsidiary names John Choe as western sales director - Investing.com
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire
He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Gardner News
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Erie Times-News
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - The Hutchinson News
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Black Hills Pioneer
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with N - GuruFocus
Aspire Biopharma Holdings Inc (ASBP) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):